FDA NDC Directory · JSON-LD · Markdown

OPDUALAG

NDC 0003-7125 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namenivolumab and relatlimab-rmbw
Labeler / ManufacturerE.R. Squibb & Sons, L.L.C.
Marketing categoryBiologic License Application · App BLA761234
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNIVOLUMAB (12 mg/mL)
RELATLIMAB (4 mg/mL)
Marketing started20220318
Package count1

External sources

Source: openFDA. Public-domain (CC0).